DYN logo

Dyne Therapeutics, Inc. (DYN) Cash From Investing

Annual CFI:

-$204.08M-$287.39M(-344.96%)
December 31, 2024

Summary

  • As of today, DYN annual cash from investing is -$204.08 million, with the most recent change of -$287.39 million (-344.96%) on December 31, 2024.
  • During the last 3 years, DYN annual cash from investing has fallen by -$66.18 million (-48.00%).
  • DYN annual cash from investing is now -334.03% below its all-time high of $87.20 million, reached on December 31, 2022.

Performance

DYN Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDYNcash flow metrics

Quarterly CFI:

-$37.97M-$44.74M(-660.45%)
September 30, 2025

Summary

  • As of today, DYN quarterly cash from investing is -$37.97 million, with the most recent change of -$44.74 million (-660.45%) on September 30, 2025.
  • Over the past year, DYN quarterly cash from investing has dropped by -$18.56 million (-95.67%).
  • DYN quarterly cash from investing is now -173.49% below its all-time high of $51.66 million, reached on September 30, 2022.

Performance

DYN Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDYNcash flow metrics

TTM CFI:

-$45.74M-$18.56M(-68.29%)
September 30, 2025

Summary

  • As of today, DYN TTM cash from investing is -$45.74 million, with the most recent change of -$18.56 million (-68.29%) on September 30, 2025.
  • Over the past year, DYN TTM cash from investing has increased by +$116.13 million (+71.74%).
  • DYN TTM cash from investing is now -139.30% below its all-time high of $116.40 million, reached on March 31, 2023.

Performance

DYN TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDYNcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

DYN Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-345.0%-95.7%+71.7%
3Y3 Years-48.0%-173.5%-167.5%
5Y5 Years-10000.0%--

DYN Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-334.0%at low-173.5%+78.9%-139.3%+77.6%
5Y5-Year-334.0%at low-173.5%+78.9%-139.3%+77.6%
All-TimeAll-Time-334.0%at low-173.5%+78.9%-139.3%+77.6%

DYN Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2025
-
-$37.97M(-660.5%)
-$45.74M(-68.3%)
Jun 2025
-
$6.77M(+364.6%)
-$27.18M(-19.3%)
Mar 2025
-
$1.46M(+109.1%)
-$22.78M(+88.8%)
Dec 2024
-$204.08M(-345.0%)
-$16.01M(+17.5%)
-$204.08M(-26.1%)
Sep 2024
-
-$19.40M(-273.6%)
-$161.87M(-24.9%)
Jun 2024
-
$11.17M(+106.2%)
-$129.65M(-4.9%)
Mar 2024
-
-$179.84M(-786.5%)
-$123.59M(-248.3%)
Dec 2023
$83.31M(-4.5%)
$26.20M(+104.3%)
$83.31M(+9.1%)
Sep 2023
-
$12.82M(-25.6%)
$76.35M(-33.7%)
Jun 2023
-
$17.23M(-36.3%)
$115.19M(-1.0%)
Mar 2023
-
$27.06M(+40.7%)
$116.40M(+33.5%)
DateAnnualQuarterlyTTM
Dec 2022
$87.20M(+163.2%)
$19.24M(-62.8%)
$87.20M(+28.7%)
Sep 2022
-
$51.66M(+180.1%)
$67.73M(+412.2%)
Jun 2022
-
$18.44M(+963.4%)
$13.22M(+213.5%)
Mar 2022
-
-$2.14M(-808.9%)
-$11.65M(+91.5%)
Dec 2021
-$137.89M(-202.0%)
-$235.00K(+91.7%)
-$137.89M(+24.6%)
Sep 2021
-
-$2.85M(+55.7%)
-$182.88M(-1.6%)
Jun 2021
-
-$6.43M(+95.0%)
-$180.03M(-3.7%)
Mar 2021
-
-$128.38M(-183.9%)
-$173.60M(-283.9%)
Dec 2020
-$45.66M(-2672.4%)
-$45.22M(-6036.1%)
-$45.22M(-6036.1%)
Dec 2019
-$1.65M(-1129.1%)
-$737.00K
-$737.00K
Dec 2018
-$134.00K
-
-

FAQ

  • What is Dyne Therapeutics, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Dyne Therapeutics, Inc.?
  • What is Dyne Therapeutics, Inc. annual cash from investing year-on-year change?
  • What is Dyne Therapeutics, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Dyne Therapeutics, Inc.?
  • What is Dyne Therapeutics, Inc. quarterly cash from investing year-on-year change?
  • What is Dyne Therapeutics, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Dyne Therapeutics, Inc.?
  • What is Dyne Therapeutics, Inc. TTM cash from investing year-on-year change?

What is Dyne Therapeutics, Inc. annual cash from investing?

The current annual cash from investing of DYN is -$204.08M

What is the all-time high annual cash from investing for Dyne Therapeutics, Inc.?

Dyne Therapeutics, Inc. all-time high annual cash from investing is $87.20M

What is Dyne Therapeutics, Inc. annual cash from investing year-on-year change?

Over the past year, DYN annual cash from investing has changed by -$287.39M (-344.96%)

What is Dyne Therapeutics, Inc. quarterly cash from investing?

The current quarterly cash from investing of DYN is -$37.97M

What is the all-time high quarterly cash from investing for Dyne Therapeutics, Inc.?

Dyne Therapeutics, Inc. all-time high quarterly cash from investing is $51.66M

What is Dyne Therapeutics, Inc. quarterly cash from investing year-on-year change?

Over the past year, DYN quarterly cash from investing has changed by -$18.56M (-95.67%)

What is Dyne Therapeutics, Inc. TTM cash from investing?

The current TTM cash from investing of DYN is -$45.74M

What is the all-time high TTM cash from investing for Dyne Therapeutics, Inc.?

Dyne Therapeutics, Inc. all-time high TTM cash from investing is $116.40M

What is Dyne Therapeutics, Inc. TTM cash from investing year-on-year change?

Over the past year, DYN TTM cash from investing has changed by +$116.13M (+71.74%)
On this page